Customize your JAMA Network experience by selecting one or more topics from the list below.
In the article titled “Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program”1 published in the October 2018 print issue of JAMA Internal Medicine, there was an error in the second-to-last column heading of Table 2. The heading “Risks-Outweigh-Benefits Vote, No., Yes/No/Abstention” should have been “Benefits-Outweigh-Risks Vote, No., Yes/No/Abstention.” This article has been corrected online.
Error in Table 2. JAMA Intern Med. 2019;179(5):733. doi:10.1001/jamainternmed.2019.1493
Coronavirus Resource Center
Create a personal account or sign in to: